FDA ac­cepts Iver­ic Bio's NDA, grants pri­or­i­ty re­view for GA drug

On the heels of a sec­ond Phase III win in ge­o­graph­ic at­ro­phy last year, Iver­ic Bio is now wait­ing at the FDA’s doors for its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.